Your browser doesn't support javascript.
loading
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity.
Bae, Seongman; Ko, Jae-Hoon; Choi, Ju-Yeon; Park, Woo-Jung; Lim, So Yun; Ahn, Jin Young; Song, Kyoung-Ho; Lee, Kyoung Hwa; Song, Young Goo; Chan Kim, Yong; Park, Yoon Soo; Choi, Won Suk; Jeong, Hye Won; Kim, Shin-Woo; Kwon, Ki Tae; Kang, Eun-Suk; Kim, Ah-Ra; Jang, Sundong; Kim, Byoungguk; Kim, Sung Soon; Jang, Hee-Chang; Choi, Jun Yong; Kim, Sung-Han; Peck, Kyong Ran.
  • Bae S; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ko JH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Choi JY; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Park WJ; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Lim SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ahn JY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Song KH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Lee KH; Division of Infectious Diseases, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Song YG; Division of Infectious Diseases, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Chan Kim Y; Division of Infectious Disease, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
  • Park YS; Division of Infectious Disease, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
  • Choi WS; Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea.
  • Jeong HW; Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea.
  • Kim SW; Department of Internal Medicine, Kyungpook National University, School of Medicine, Daegu, South Korea.
  • Kwon KT; Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Kang ES; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kim AR; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Jang S; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Kim B; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Kim SS; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Jang HC; National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Chungcheongbuk-do, South Korea.
  • Choi JY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: seran@yuhs.ac.
  • Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: kimsunghanmd@hotmail.com.
  • Peck KR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: krpeck@skku.edu.
Clin Microbiol Infect ; 28(10): 1390.e1-1390.e7, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35598855

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article